Enfortumab vedotin and pembrolizumab as monotherapies and combination treatment in locally advanced or metastatic urothelial carcinoma: A narrative review

BACKGROUND: Bladder cancer is the 10th most common cancer globally. The majority of bladder cancers are urothelial carcinomas (UCs), which, if locally advanced or metastatic, carry poor long-term prognosis. Cancer cells can evade the immune system by expressing the programmed cell death ligand 1 pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bantounou, Maria A., Plascevic, Josip, MacDonald, Lewis, Wong, Man Chun, O'Connell, Neasa, Galley, Helen F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662875/
https://www.ncbi.nlm.nih.gov/pubmed/37994340
http://dx.doi.org/10.1097/CU9.0000000000000204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662875/
https://www.ncbi.nlm.nih.gov/pubmed/37994340
http://dx.doi.org/10.1097/CU9.0000000000000204

Ejemplares similares